Skip to main content
Back to News
OpenAI unveiled GPT‑Rosalind, a biology‑tuned LLM designed for evidence synthesis, hypothesis genera...
Product
1 min read
US

OpenAI unveiled GPT‑Rosalind, a biology‑tuned LLM designed for evidence synthesis, hypothesis genera...

The AMW Read

This updates the OpenAI case study (01.§4) by demonstrating a significant vertical expansion into high-value biology/drug discovery workflows, validated by top-tier industry adopters like Amgen and Moderna.
NoveltySignificance
Healthcare & Bio · Player MapFoundation Models · Case Studies
Codex
Codex

AI in Fintech

View Company Profile

OpenAI unveiled GPT‑Rosalind, a biology‑tuned LLM designed for evidence synthesis, hypothesis generation and experimental planning in drug discovery and translational medicine. The model is available via a research preview in ChatGPT, Codex and API, with a free Life Sciences plugin linking to 50+ scientific tools. Early adopters include Amgen, Moderna and Thermo Fisher, signaling a shift toward AI‑driven acceleration of early‑stage research. 🚀

#AI #LifeSciences #DrugDiscovery #Biotech #OpenAI

Explore CodexRead Original

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1d agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  2. 4d agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  3. 4d agoGenBio AI, a Palo Alto-based AI company co-founded by Nobel laureate David Baker, has released AIDO...GenBio AI
  4. 4mo agoOpenAI unveiled GPT‑Rosalind, a biology‑tuned LLM designed for evidence synthesis, hypothesis genera... · THIS ARTICLE

Related News

OpenAI updates Codex with autonomous macOS control, memory, and new plugins to compete with Anthropic's Claude Code.
Product•April 17, 2026

OpenAI updates Codex with autonomous macOS control, memory, and new plugins to compete with Anthropic's Claude Code.

Temporal just raised $300M at a $5B valuation to solve AI's production reliability problem. Their pl...
Funding•February 18, 2026

Temporal just raised $300M at a $5B valuation to solve AI's production reliability problem. Their pl...

View all news

More news from Codex

Stay updated with the latest news and announcements from Codex.

View all Codex news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard